9,733
Total Claims
$543K
Drug Cost
949
Beneficiaries
$572
Cost/Patient
Peer Comparison vs. 110,156 Internal Medicine providers
-59%
Cost per patient vs peers
$572 vs $1,411 avg
-13%
Brand preference vs peers
9.2% vs 10.6% avg
Brand vs Generic
91% generic
Brand: 890 claims · $373K
Generic: 8,753 claims · $168K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 53 | $74K |
| Semaglutide | 55 | $60K |
| Rivaroxaban | 17 | $26K |
| Tirzepatide | 19 | $21K |
| Sitagliptin Phosphate | 19 | $15K |
| Levothyroxine Sodium | 636 | $10K |
| Levothyroxine Sodium | 81 | $8,809 |
| Atorvastatin Calcium | 591 | $6,522 |
| Rosuvastatin Calcium | 441 | $5,653 |
| Omeprazole | 302 | $4,261 |
| Bupropion Hcl | 80 | $4,221 |
| Escitalopram Oxalate | 258 | $3,976 |
| Duloxetine Hcl | 125 | $3,802 |
| Amlodipine Besylate | 437 | $3,553 |
| Ipratropium Bromide | 53 | $3,435 |
Prescribing Profile
Patient Profile
77
Avg Age
73%
Female
1.32
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data